Skip to content
LexBuild

New Animal Drugs; Change of Sponsor's Address

---
identifier: "/us/fr/02-17405"
source: "fr"
legal_status: "authoritative_unofficial"
title: "New Animal Drugs; Change of Sponsor's Address"
title_number: 0
title_name: "Federal Register"
section_number: "02-17405"
section_name: "New Animal Drugs; Change of Sponsor's Address"
positive_law: false
currency: "2002-07-11"
last_updated: "2002-07-11"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-17405"
document_type: "rule"
publication_date: "2002-07-11"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 510"
fr_citation: "67 FR 45900"
fr_volume: 67
effective_date: "2002-07-11"
fr_action: "Final rule."
---

#  Names, addresses, and drug labeler codes of sponsors of approved applications.

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Final rule.

**SUMMARY:**

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's address for BioScience Division of Milk Specialties Co.

**DATES:**

This rule is effective July 11, 2002.

**FOR FURTHER INFORMATION CONTACT:**

Lonnie W. Luther, Center for Veterinary Medicine (HFV-101), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0209, e-mail: [email protected].

**SUPPLEMENTARY INFORMATION:**

BioScience Division of Milk Specialties Co., Illinois and Water Sts., P.O. Box 278, Dundee, IL 60118, has informed FDA of a change of sponsor's address to 1902 Tennyson Lane, Madison, WI 53704. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the change.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

**List of Subjects in 21 CFR Part 510**

Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.

**21 CFR Part 510**

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows:

1. The authority citation for 21 CFR part 510 continues to read as follows:

**Authority:**

21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

2. Section 510.600 is amended in the table in paragraph (c)(1) by revising the entry for “BioScience Division of Milk Specialties Co.” and in the table in paragraph (c)(2) by revising the entry for “032761” to read as follows:

§ 510.600

(c) * * *

(1) * * *

| Firm name and address | Drug labeler code |
| --- | --- |
| *         *         *         *         *         *         * |  |
| BioScience Division of Milk Specialties Co., 1902 Tennyson Lane, Madison, WI  53704 | 032761 |
| *         *         *         *         *         *         * |  |

(2) * * *

| Drug labeler code | Firm name and address |
| --- | --- |
| *         *         *         *         *         *         * |  |
| 032761 | BioScience Division of Milk Specialties Co., 1902 Tennyson Lane, Madison, WI  53704 |
| *         *         *         *         *         *         * |  |

Dated: May 28, 2002.

Andrew J. Beaulieu,

Acting Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.